Startup 62° Simposio AFI

David Edwards (SC Therapeutics, US)

David A. Edwards is a long-standing professor of the practice of biomedical engineering at Harvard University (2002-2019), currently Associate in the John Paulson School of Engineering & Applied Sciences at Harvard University, Adjunct Professor at Johns Hopkins Medical School, and founder and CSO of Sensory Cloud Inc. A pioneer of aerosol medicine and biophysics, David's previous companies have led to the FDA-approved Inbrija (inhaled L Dopa for Parkinsons), edible packaged food (2014 Time Magazine Invention of the Year, currently on the US market as Foodberries) and airway hygiene (2020 Time Magazine Invention of the Year, currently on the US market as FEND). Sensory Cloud is pioneering aerosol products that resolve endemic dehydration of the upper airways for the treatment of respiratory illnesses such as refractory chronic cough. David has won multiple international awards for his scientific and translational work, and is a member of the US National Academy of Engineering, the US National Academy of Inventors, and the French National Academy of Engineering (Académie nationale d'ingénieurs), as well as a Chevallier des arts et des lettres from the French Ministry of Culture. He is the author of multiple books including Creating Things That Matter (Holt), winner of the 2018 Nautilus Book Award for the category of creativity.

Justin Hanes (Johns Hopkins University, US)

Dr. Hanes the Lewis J. Ort Professor and founding Director of the Center for Nanomedicine at the Johns Hopkins University School of Medicine, where he holds faculty appointments in the departments of Ophthalmology (primary), Biomedical Engineering, Chemical & Biomolecular Engineering, Neurosurgery, Oncology, and Physiology, Pharmacology & Therapeutics. A member of the National Academy of Engineering, National Academy of Medicine and National Academy of Inventors of the US, and inductee into the EU Academy of Sciences, he is an expert in the areas of advanced drug and gene delivery systems and pharmaceutical formulation, polymer and lipid nanoparticles, nanoparticle-tissue interactions, nanoparticle and drug transport in biological fluids and tissues, and drug delivery for a wide array of diseases affecting nearly all parts of the body. He is the most recent recipient of the Thomas T. Mercer Joint Prize in pharmaceutical aerosols and inhalable materials from AAAR and ISAM. He is an inventor on more than 180 US patents and patent applications focused in the area of advanced delivery systems that make drugs and gene therapies safer and more effective. Technologies he developed with co-inventors have served as the basis for the launch of several companies, including Advanced Inhalation Research (acquired by Alkermes), Civitas Therapeutics (acquired by Acorda Therapeutics), Kala Pharmaceuticals (Nasdaq: KALA), GrayBug Vision (Nasdaq: GRAY; acquired by CalciMedica), NovusBio (private) and Novus Vision (private). He is also a founder of Theraly Pharmaceuticals (acquired by D&D Pharmatech), Theraly Fibrosis (acquired by D&D Pharmatech), Neuraly (acquired by D&D Pharmatech), Spiral Therapeutics (private), Ashvattha Therapeutics (private), and Orpheris (acquired by Ashvattha Therapeutics). Dr. Hanes has helped these companies raise more than $1 billion USD and to create multiple FDA-approved drugs and more than two dozen products that have been tested, or are currently being tested, in human clinical trials. Dr. Hanes is a Venture Partner at Catalio Capital Management, where he has served as an advisor since the genesis of the company, including as Chief Scientist of the Nexus II fund. He has served on the scientific advisory boards for pharmaceutical companies, including Genentech in the Drug Delivery Division and ReCode Therapeutics, and he is a past chair of the Gene and Drug Delivery Study Section of the National Institutes of Health. He has served as the President of the Controlled Release Society and he is a fellow of several scientific societies. Dr. Hanes has received multiple school-wide teaching awards at the Johns Hopkins University.

Sabato 19 Settembre 2026

10.00 - 10.15
Apertura Convegno

Prof.ssa Paola Minghetti, Presidente SIFAP
Prof.ssa Chiara Leardini, Magnifica Rettrice, Università degli Studi di Verona
Prof. Giuseppe Lippi, Preside della Facoltà di Medicina, Università degli Studi di Verona
Prof. Cristiano Chiamulera, Presidente Corso di studi in Farmacia, Università degli Studi di Verona
Dr. Federico Realdon Ordine dei Farmacisti della Provincia di Verona
Dott.ssa Elena Vecchioni Federfarma Verona

10.15 - 12.00
Sessione Istituzionale
"Parlando di Galenica con..."

Modera Prof.ssa Paola Minghetti, Presidente SIFAP

Dr. Andrea Mandelli, Presidente Federazione Ordini dei Farmacisti Italiani
Dr. Marco Cossolo, Presidente Federfarma
Dr. Arturo Cavaliere, Presidente SIFO
Dr. Luigi D’Ambrosio Lettieri, Presidente Fondazione Cannavò
Dr. Eugenio Leopardi, Presidente UTIFAR
Dr. Francesco Ferro Russo, Presidente FENAGIFAR
Dott.ssa Eugenia Cogliandro, Presidente Commissione Farmacopea Europea
Dr.ssa Giovanna Scroccaro, Direttore Direzione Farmaceutico, protesica e dispositivi medici Regione Veneto

Conferimento Premi Marcello Marchetti

12.00 - 13.30
Pausa pranzo

13.30 - 14.00
Walking Poster

14.00 - 16.00
Tavola rotonda
"Innovazione nel campo delle materie prime e delle tecnologie di laboratorio"

Moderano Dr. Marco Fortini e Dr. Bruno Bizzaro

Magistra: nuova interfaccia per gli utilizzatori ed integrazione con dispositivi di produzione - Dr. Stefano Barontini, Galeno Sistemi

L’essenzialità della camera sterile: il ruolo strategico degli specialisti della galenica - Dr. Massimiliano Cecchi, Consulente Phamm Engineering

Medical Dispenser: confezionamento personalizzato dei medicinali per migliorare l’aderenza terapeutica - Dr. Alessandro Crespi, Farmalabor

Xeo filler. Dalla mente alla macchina: l’innovazione galenica del riempimento polveri attraverso intelligenze integrate - Dr. Adalberto Fabbriconi, Gamma Pharmacy Equipment

Attivi complessi e forme intelligenti: tecnologie galeniche per il drug delivery personalizzato - Dott.ssa Rosalba Lombardo, Acef

Sistemi farmaceutici innovativi per la somministrazione orale - Dott.ssa Tatiana Selleri, Fagron

16.00 - 16.40
Coffee break e Sessione Poster

16.40 - 17.50
Galenica senza confini: esperienze che ispirano il futuro

Moderano Dr. Salvatore Messana e Dr. Annunziata Lombardi

Uno sguardo alla preparazione Galenica in Francia - Dr. Fabien BRUNO, Farmacéutico, Farmacia Delpech Paris

Uno sguardo alla preparazione Galenica in Spagna - Dr. Izaskun Malo, Farmacéutica formulista, MÁLAGA

Uso responsabile degli antimicrobici: anche il farmacista preparatore può contribuire? - Dr. Federico Zerbinato, Farmacista di Comunità

17.50 - 18.30
Consegna Certificazioni Farmacista Preparatore

Prof.ssa Paola Minghetti - Presidente SIFAP
Dott.ssa Francesca Rauzi - Vicepresidente Unifarm

20.00 - 23.00
Cena Sociale presso Yard Restaurant, in collaborazione con

STARTUP SIMPOSIO

Sidebar Video Congresso SIFAP